In NASDAQ: AXSM, NYSE: ABT, NYSE: BMY, NYSE: BSX, NYSE: GSK, NYSE: MDT, NYSE: NVRO, NYSE: NVS, OTCQB: EMED
Posted Electromedical Technologies, Inc. (OTCQB: EMED) Positioned For The Future With WellnessPro™Plus And Planned Wellness Pro® Pod With ‘Future-Ready’ FDA-Cleared Device That Treats Chronic And Acute Pain; EMED Addresses Opioid Abuse Market And $151.7 Billion Chronic Pain Market Seen By 2030
Electromedical Technologies, Inc. (OTCQB: EMED) is positioned for the future. The company, recently up listed to the OTCQB market, is fighting opioid abuse with its FDA-cleared WellnessPro™ [...]